First AD

Second AD

Optimizing TKI Selection and Sequencing Strategies in Advanced GIST Beyond First-Line Therapy

Video Series

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

My Treatment Approach Beyond the First-Line: Expert Insights on Evidence-Driven TKI Selection and Sequencing in Advanced GIST

OncLive Insights

Experts discuss optimizing TKI selection and sequencing strategies for advanced gastrointestinal stromal tumors (GIST) beyond first-line therapy, focusing on the latest clinical data, molecular characterization, and insights from recent trials to guide treatment decisions.

Biological Mechanisms of GIST Resistance and Tumor Heterogeneity

Monitoring Tumor Heterogeneity and Detecting Resistance

Post-Imatinib Progression: Decision Factors and Treatment Options

INVICTUS Trial: Ripretinib in Fourth-Line Setting

INTRIGUE Trial: Key Findings in Second-Line Setting

ctDNA Biomarkers in INTRIGUE: Understanding Resistance Patterns

Managing Adverse Events With Different TKIs

Next-Generation Treatment Strategies for GIST: Evaluating Combination Therapies and Mutation-Specific Approaches

Practical Recommendations for Community Oncologists